Clue has extended an invite to its user community to become investors via Crowdcube
The pharma industry funnels only two per cent of annual revenue from contraceptives back into research and development
The company’s currently ongoing Phase IIb pre-pivotal clinical study assesses the safety and efficacy of the IUB™ SEAD
The survey of 1,000 women has revealed almost half of respondents were unable to exercise due to menstrual symptoms
The test aims to help clinicians accurately test and treat patients in a single visit
The Apple Women’s Health Study invites women to contribute to scientific research by enrolling via the Apple Research app
The developers say the device could provide an alternative diagnostic test to the Pap smear
The platform will allow users to monitor symptoms, treatment and patterns
Visitors will have access to online consultations and pharmaceutical treatment for menstrual, sexual and menopausal health concerns
Phexxi will be the first and only hormone-free contraceptive offered by Favor
